Q1 2018 Holdings
Filed 2018-05-15 | 18 holdings | $56.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $31.1M | 475,419 | 55.3% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $10.0M | 650,000 | 17.8% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $7.5M | 429,551 | 13.4% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $7.4M | 1,485,245 | 13.2% |
| Insmed Incorporated(INSM) | COM | 457669307 | $40.5K | 1,799,225 | 0.1% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $27.4K | 2,111,869 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $21.9K | 851,200 | 0.0% |
| Myokardia, Inc. | COM | 62857M105 | $19.1K | 391,955 | 0.0% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $15.7K | 1,073,272 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $13.2K | 560,073 | 0.0% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $10.6K | 830,919 | 0.0% |
| OptiNose, Inc. | COM | 68404V100 | $9.7K | 483,606 | 0.0% |
| Alder BioPharmaceuticals, Inc.Put | COM | 014339955 | $7.9K | 450,000 | 0.0% |
| Insmed IncorporatedPut | COM | 457669957 | $6.8K | 300,000 | 0.0% |
| Myokardia, Inc.Put | COM | 62857M955 | $4.9K | 100,000 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $4.0K | 200,000 | 0.0% |
| Ra Pharmaceuticals, Inc. | COM | 74933V108 | $2.4K | 450,000 | 0.0% |
| Solid Biosciences Inc. | COM | 83422E105 | $1.1K | 140,332 | 0.0% |